Marine sponges are evolutionary multicellular organisms that have been reported as the best producers of bioactive compounds, which have antibacterial, antifungal, anticancer and cytotoxic properties [1] . The limitations of sponge biomass and ecological problems such as marine environmental damage and sponge extinction are the main factor for isolating the large scale bioactive compounds. Interestingly, a previous research showed that 40-60 % of sponge biomass is symbiotic microorganisms that can produce metabolite compounds similar to those produced by the host. It is hypothesized that symbiotic marine-microorganisms harbored by sponges are the original producers of these bioactive compounds [2] . Previous studies had revealed the antioxidant and anticancer activity of bacterial crude extracts isolated from sponge Jaspis sp. against human cervix HeLa cells and leukemic cell lines [3,4] . In addition, crude extract of Bacillus sp. isolated from sponge Haliclona sp. was also reported to have anticancer activity against MOLT4 cells and its activity is related to NRPS-PKS genes to encode the bioactive compounds [5] .Antioxidant activity plays an important role in cellular physiology as it has the ability to neutralize and prevent free radicals, including reactive oxygen species (ROS) and its derivatives, from damaging cells. However, an imbalance between ROS production and antioxidant defence may lead to oxidative stress, which may cause degenerative diseases such as cancer, Alzheimer's, cardiovascular, aging and neurological disorders [6] .
Plant Growth Promoting Rhizobacteria (PGPR) is considered as the biological agent for improving plant growth. One Group of PGPR that have an important role in growth promoting of plant is Actinomycetes. The objective of this study was to isolate and screen Actinomycetes isolated from soybean rhizosphere as growth promoter of soybean in vitro. Fifty-three Actinomycetes isolates have successfully been isolated from soybean rhizosphere using two media, mainly Humic acid Vitamin Agar (HVA) and starch casein agar (SCA). Among 53 isolates, 18 (34%) isolates were able to produce IAA in range of 2.08 ppm to 16.70 ppm. Growth promotion test of soybean in vitro using Ragdoll method resulted 7 Actinomycetes isolates that significantly enhanced 3 plant growth parameters, including hypocotyl and radicular length as well as the number of lateral roots. Of those 7 isolates of Actinomycetes, 5 isolates were able to grow on nitrogen-free medium and solubilize phosphate. Those 5 isolates also were found as non-pathogenic, based on the negative reaction in hypersensitivity test. Based on 16S rRNA sequence analysis, 5 selected Actinomycetes isolates were highly homolog with Streptomyces genera in different taxa of species and strains (similarity ≥99%). Our finding reveals a potent application of 5 Actinomycetes isolates as plant growth promoter in soybean agriculture.
Compared to the widely explored antioxidant activity from the clove bud extract, less data are available regarding the potential pharmacological use of clove leaves. Our study aimed to explore the antioxidant activity of clove leaves extract in the cellular level. Thus, we used the yeast Schizosaccharomyces pombe as model organisms. Our data indicate that, following extract treatment (100 ppm), the viability of the stationary phase cells of S. pombe was higher than without extract and that of calorie restriction treatments. 100 ppm extract treatment also increased cell viability against H2O2-induced oxidative stress. Those data indicate that the extract could promote oxidative stress tolerance response in yeast cells, which occurred either during the stationary phase or due to exogenous exposure. Higher dose of extract (500 ppm) showed opposite effects, as cell viability was lower than that without treatment. Analysis toward the mitochondrial activity revealed that the extract did not induce mitochondrial activity unlike the calorie restriction treatment. Based on our data, clove leaf extract promotes oxidative stress tolerance response in the yeast S. pombe, independent to that mitochondrial adaptive ROS signaling which commonly occurs in calorie restriction-induced oxidative stress tolerance response.
As a cellular signaling molecule, nitric oxide (NO) is widely conserved from microorganisms, such as bacteria, yeasts, and fungi, to higher eukaryotes including plants and mammals. NO is mainly produced by NO synthase (NOS) or nitrite reductase (NIR) activity. There are several NO detoxification systems, including NO dioxygenase (NOD) and S-nitrosoglutathione reductase (GSNOR). NO homeostasis based on the balance between NO synthesis and degradation is important for the regulation of its physiological functions because an excess level of NO causes nitrosative stress due to the high reactivity of NO and NO-derived compounds. In yeast, NO may be involved in stress responses, but NO and its signaling have been poorly understood due to the lack of mammalian NOS orthologs in the genome. Even though the activities of NOS and NIR have been observed in yeast cells, the gene encoding NOS and the NO production mechanism catalyzed by NIR remain unclear. On the other hand, yeast cells employ NOD and GSNOR to maintain an intracellular redox balance following endogenous NO production, exogenous NO treatment, or environmental stresses. This article reviews NO metabolism (synthesis, degradation) and its regulation in yeast. The physiological roles of NO in yeast, including the oxidative stress response, are also discussed here. Such investigations into NO signaling are essential for understanding the NO-dependent genetic and physiological modulations. In addition to being responsible for the pathology and pharmacology of various degenerative diseases, NO signaling may be a potential target for the construction and engineering of industrial yeast strains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.